Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.
Bozas G, Dimopoulos MA, Kastritis E, Efstathiou E, Koutsoukou V, Rodolakis A, Vlahos G, Voulgaris Z, Papageorgiou T, Gika D, Papadimitriou C, Bamias A. Bozas G, et al. Among authors: gika d. Oncology. 2006;70(4):265-72. doi: 10.1159/000094889. Epub 2006 Aug 4. Oncology. 2006. PMID: 16899981
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
Dimopoulos MA, Papadimitriou CA, Sarris K, Aravantinos G, Kalofonos C, Gika D, Gourgoulis GM, Efstathiou E, Skarlos D, Bafaloukos D. Dimopoulos MA, et al. Among authors: gika d. Gynecol Oncol. 2002 Jun;85(3):476-82. doi: 10.1006/gyno.2002.6649. Gynecol Oncol. 2002. PMID: 12051877 Clinical Trial.
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
Bamias A, Papadimitriou C, Efstathiou E, Rodolakis A, Vlahos G, Voulgaris Z, Bozas G, Fountzilas G, Aravantinos G, Razis E, Gika D, Dimopoulos MA. Bamias A, et al. Among authors: gika d. BMC Cancer. 2006 Sep 25;6:228. doi: 10.1186/1471-2407-6-228. BMC Cancer. 2006. PMID: 16999858 Free PMC article.
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
Bozas G, Terpos E, Gika D, Karadimou A, Dimopoulos MA, Bamias A. Bozas G, et al. Among authors: gika d. Int J Gynecol Cancer. 2010 Feb;20(2):248-54. doi: 10.1111/IGC.0b013e3181cc25c3. Int J Gynecol Cancer. 2010. PMID: 20134268
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
Papadimitriou CA, Fountzilas G, Aravantinos G, Kalofonos C, Moulopoulos LA, Briassoulis E, Gika D, Dimopoulos MA; Hellenic Cooperative Oncology Group Study. Papadimitriou CA, et al. Among authors: gika d. Gynecol Oncol. 2004 Jan;92(1):152-9. doi: 10.1016/j.ygyno.2003.09.021. Gynecol Oncol. 2004. PMID: 14751151 Clinical Trial.
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Kastritis E, Zervas K, Repoussis P, Michali E, Katodrytou E, Zomas A, Simeonidis A, Terpos E, Delimbassi S, Vassou A, Gika D, Dimopoulos MA; Greek Myeloma Study Group. Kastritis E, et al. Among authors: gika d. Clin Lymphoma Myeloma. 2009 Mar;9(1):50-2. doi: 10.3816/CLM.2009.n.012. Clin Lymphoma Myeloma. 2009. PMID: 19362972
66 results